Fusix Biotech GmbH

We are supported by an interdisciplinary team of scientists with a shared passion for providing safe and effective therapies for cancer patients. We are an interdisciplinary team focused on providing breakthrough immunotherapies for cancer patients. We are developing on a cutting-edge, fusion-based immuno-oncolytic therapy platform for intravenous delivery. We are currently seeking investors to support final choic of our lead candidate and final process development steps. We are developing a whole platfrom appraoch consisting of a portfolio of immuno-oncolytic products targeting a variety of tumor indications, as well as a biomarker identification platform for patient selection and companion diagnostics. We are continuously working on the development of next generation viruses containing therapeutic transgenes that are optimized for immunotherapeutic efficiency and combination therapy. Fusix Biotech is a pioneering biotechnology company founded by four passionate scientists with a shared vision to revolutionize cancer treatment by fighting cancer through fusion. Our expertise also covers clinical development, vaccine manufacturing, and commercialization.